A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study on the Efficacy and Safety of Sodium Oxybate in Pediatric Subjects with Narcolepsy with Cataplexy

被引：0
|
作者：
Wang, Y.
Plazzi, G.
Ruoff, C.
Lecendreux, M.
Dauvilliers, Y.
Rosen, C.
Black, J.
Parvataneni, R.
Guinta, D.
Mignot, E.
机构：
来源：
ANNALS OF NEUROLOGY | 2017年 / 82卷
关键词：
Translational/Experimental Therapeutics;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
136
引用
收藏
页码：S339 / S339
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Tapentadol ER for Diabetic Peripheral Neuropathic Pain: Results of a Randomized-Withdrawal, Double-Blind, Placebo-Controlled Phase III Study
    Etropolski, Mila
    Shapiro, Douglas
    Okamoto, Akiko
    Rauschkolb-Loeffler, Christine
    Haeussler, Juergen
    NEUROLOGY, 2009, 72 (11) : A217 - A218
  • [22] Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study
    Dauvilliers, Yves
    Arnulf, Isabelle
    Foldvary-Schaefer, Nancy
    Morse, Anne Marie
    Sonka, Karel
    Thorpy, Michael J.
    Mignot, Emmanuel
    Chandler, Patricia
    Parvataneni, Rupa
    Black, Jed
    Sterkel, Amanda
    Chen, Dan
    Skobieranda, Franck
    Bogan, Richard K.
    LANCET NEUROLOGY, 2022, 21 (01): : 53 - 65
  • [23] Quality of Life in a Phase 3, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study of JZP-258 in Adults with Narcolepsy with Cataplexy
    Foldvary-Schaefer, Nancy
    Thorpy, Michael J.
    Dauvilliers, Yves
    Roy, Asim
    Tang, Lihua
    Skowronski, Roman
    Sonka, Karel
    Bogan, Richard K.
    ANNALS OF NEUROLOGY, 2020, 88 : S254 - S255
  • [24] QUALITY OF LIFE IN PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED WITHDRAWAL STUDY OF JZP-258 IN ADULTS WITH NARCOLEPSY WITH CATAPLEXY
    Foldvary-Schaefer, N.
    Thorpy, M. J.
    Dauvilliers, Y.
    Roy, A.
    Tang, L.
    Skowronski, R.
    Sonka, K.
    Bogan, R. K.
    SLEEP, 2020, 43 : A281 - A282
  • [25] A Double-Blind, Placebo-Controlled Study Demonstrates Sodium Oxybate Is Effective for the Treatment of Excessive Daytime Sleepiness in Narcolepsy
    Ahmed, Mansoor
    Becker, Philip
    Biber, Michael
    Black, Jed
    Bogan, Richard
    Chesson, Andrew, Jr.
    Cook, James
    Duntley, Stephen
    Emsellem, Helene
    Chase, Chevy
    Erman, Milton
    Hayduk, Roza
    Feldman, Neil
    Fleming, John
    Geisler, Peter
    Hagaman, Martha
    Hill, Dennis
    Houghton, William C.
    Hornfeldt, Carl S.
    Husain, Aatif M.
    Kaelin, Thomas
    Lammers, Gert Jan
    Lankford, D. Alan
    Leech, Judith
    Mamelak, Mortimer
    Mayer, Geert
    Moldofsky, Harvey
    Montplaisir, Jacques
    Morehouse, Rachel
    Moscovitch, Adam
    Nevsimalova, Sonka
    Orr, William
    Pascualy, Ralph
    Pegram, Vernon
    Perkins, Thomas
    Phadke, Jayant
    Ristanovic, Ruzica
    Shneerson, John
    Stevens, James
    Swick, Todd
    Walsleben, Joyce
    Walter, Timothy
    Ware, J. Catesby
    Whitten, Patrick
    Winslow, David
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2005, 1 (04): : 391 - 397
  • [26] Efficacy and Safety of "URSA Complex" in Subjects with Physical Fatigue: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
    Kim Kwang-Min
    Kim Moon-Jong
    Song Sang-Wook
    Cho Doo-Yeoun
    Park Kyung-Chae
    Yang Sung-Won
    Kim Young-Sang
    Kim Kyung-Soo
    中华医学杂志(英文版), 2016, 129 (02) : 129 - 134
  • [27] Efficacy and Safety of "URSA Complex" in Subjects with Physical Fatigue: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
    Kim, Kwang-Min
    Kim, Moon-Jong
    Song, Sang-Wook
    Cho, Doo-Yeoun
    Park, Kyung-Chae
    Yang, Sung-Won
    Kim, Young-Sang
    Kim, Kyung-Soo
    CHINESE MEDICAL JOURNAL, 2016, 129 (02) : 129 - 134
  • [28] A randomized, double-blind, placebo-controlled trial of sodium oxybate in fibromyalgia syndrome [FMS]
    Patkar, A. A.
    Bennett, R. M.
    Michalek, J. E.
    Cook, H.
    Perera, P.
    Masand, P.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S137 - S137
  • [29] Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients
    Ahmed M.
    Bassetti C.
    Becker P.
    Michael B.
    Black J.
    Bogan R.
    Chesson Jr. A.
    Cook J.
    Duntley S.
    Emsellem H.
    Ermine M.
    Hayduk R.
    Feldman N.
    Fleming J.
    Geisler P.
    Hagaman M.
    Hill D.
    Houghton W.C.
    Hornfeldt C.S.
    Husain A.M.
    Kaelin T.
    Lammers G.J.
    Lankford D.A.
    Leech J.
    Mamelak M.
    Mayer G.
    Moldofsky H.
    Montplaisir J.
    Morehouse R.
    Moscovitch A.
    Nevsimalova S.
    Sonka K.
    Orr W.
    Pascualy R.
    Pegram V.
    Perkins T.
    Phadke J.
    Ristanovic R.
    Shneerson J.
    Stevens J.
    Swick T.
    Walsleben J.
    Walter T.
    Ware J.C.
    Whitten P.
    Winslow D.
    SLEEP MEDICINE, 2005, 6 (05) : 415 - 421
  • [30] Changes in Cataplexy Frequency by Therapy at Study Entry in a Phase 3, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study of JZP-258 in Adults with Narcolepsy with Cataplexy
    Thorpy, Michael J.
    Sonka, Karel
    Bogan, Richard K.
    Partinen, Markku
    Villegas, Rafael Del Rio
    Foldvary-Schaefer, Nancy
    Skowronski, Roman
    Tang, Lihua
    Skobieranda, Franck
    Dauvilliers, Yves
    ANNALS OF NEUROLOGY, 2020, 88 : S254 - S254
12345